Medicare Enrolled
Dr. Jordan Deaner, MD
Ophthalmology · Philadelphia, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Deaner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deaner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Deaner
Dr. Jordan Deaner is an ophthalmology specialist in Philadelphia, PA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Deaner performed 15,072 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Deaner received a total of $17,758 from 17 pharmaceutical and/or device companies across 77 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Deaner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years of NPI registration
▲ Top 7% volume in PA
$17,758 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗15,072
Medicare services
Top 7% in PA for ophthalmology
Not available
Unique patients (not deduplicated)
$136
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
4,620 | $29 | $73 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
2,401 | $30 | $145 |
| Injection, ranibizumab, 0.1 mg | 1,467 | $190 | $900 |
| Ranibizumab-eqrn injection, 0.1 mg An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose. |
1,455 | $217 | $800 |
| Aflibercept eye injection (Eylea) | 1,224 | $692 | $2,433 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,144 | $97 | $468 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
1,129 | $67 | $195 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
474 | $90 | $275 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
324 | $123 | $355 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
217 | $159 | $500 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
137 | $19 | $85 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
93 | $36 | $212 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
80 | $1 | $4 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
65 | $28 | $215 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
50 | $75 | $456 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
37 | $113 | $435 |
| Retinal detachment repair with fluid drainage A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina. |
31 | $939 | $6,835 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
26 | $115 | $330 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
24 | $658 | $4,080 |
| Injection into eye membrane A procedure involving the injection of a drug or substance into the membrane that covers the eyeball. |
20 | $41 | $336 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
15 | $193 | $2,379 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
14 | $917 | $6,125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $81 | $235 |
| Complex detached retina repair with eye fluid drainage A surgical procedure to repair a detached retina and drain fluid located between the lens and the retina. |
12 | $1,081 | $7,425 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$17,758
Total received (2018-2024)
Avg $2,537/year across 7 years
Top 8% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
77
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,583
2023
$5,150
2022
$3,665
2021
$773
2020
$186
2019
$1,997
2018
$404
Payments by company (2024)
Regeneron Pharmaceuticals, Inc.
$2,896
Bausch & Lomb Americas Inc.
$1,256
Regeneron Healthcare Solutions, Inc.
$852
Alimera Sciences, Inc.
$219
Genentech USA, Inc.
$176
Alcon Vision LLC
$130
Boston Scientific Corporation
$53
Top 3 companies account for 89.6% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Pharmaceuticals, Inc.
$7,514
EyePoint Pharmaceuticals US, Inc.
$2,947
Bausch & Lomb, a division of Bausch Health US, LLC
$1,486
Bausch & Lomb Americas Inc.
$1,391
Regeneron Healthcare Solutions, Inc.
$1,260
Alimera Sciences, Inc.
$897
Alcon Vision LLC
$574
Glaukos Corporation
$449
Genentech USA, Inc.
$398
Alcon Research Ltd
$266
Dutch Ophthalmic, USA
$154
Genentech, Inc.
$120
Novartis Pharmaceuticals Corporation
$107
Johnson & Johnson Surgical Vision, Inc.
$79
Boston Scientific Corporation
$69
Ocular Therapeutix, Inc.
$27
Apellis Pharmaceuticals, Inc.
$20
Top 3 companies account for 67.3% of all-time payments
Associated products mentioned in payments ›
AcrySof IQ PanOptix · Clareon · Constellation · DEXTENZA · DEXYCU · EVA · EYLEA · EYLEA HD · ILUVIEN · STELLARIS · STELLARIS ELITE · STELLARIS PC · SUSVIMO · Stellaris · Tecnis Multifocal Family of 1-piece IOLS · VABYSMO · Vabysmo · WaveWriter Alpha Prime 16 · XIIDRA · XIPERE · YUTIQ · combined machine · iStent inject Trabecular Micro-Bypass Stent System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
531
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Deaner is a mixed practice specialist, with above-average Medicare volume (top 7% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Deaner experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Deaner performed 4,620 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Deaner receive payments from pharmaceutical companies?
Yes. Dr. Deaner received a total of $17,758 from 17 companies across 77 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deaner's costs compare to other ophthalmologists in Philadelphia?
Dr. Deaner's average Medicare payment per service is $136. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deaner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Philadelphia
Browse ophthalmologists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in PA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in PA
Which PA ophthalmologists receive the most from drug and device companies.
By company
Regeneron Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Pharmaceuticals, Inc.
By company
EyePoint Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from EyePoint Pharmaceuticals US, Inc.
By company
Bausch & Lomb, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Bausch & Lomb, a division of Bausch Health US, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology